Incorporating human leukocyte antibody results into clinical practice

Anat R. Tambur*, Jacob Lavee

*Corresponding author for this work

Research output: Contribution to journalEditorial


The use of human leukocyte antigen (HLA) antibody testing by solid-phase assay has improved both the specificity and sensitivity of HLA antibody detection. It did, however, introduce questions regarding interpretation of crossmatch results in light of these additional data. Herein we provide a clinician's and a laboratory professional's perspective on incorporating HLA results into clinical practice. We strongly encourage fostering ongoing dialog between the two disciplines to develop appropriate, specific guidelines.

Original languageEnglish
Pages (from-to)851-856
Number of pages6
JournalJournal of Heart and Lung Transplantation
Issue number7
StatePublished - 1 Jul 2016


  • HLA antibodies
  • donor specific antibodies
  • heart transplantation
  • solid-phase assays
  • virtual crossmatch


Dive into the research topics of 'Incorporating human leukocyte antibody results into clinical practice'. Together they form a unique fingerprint.

Cite this